"Life Sciences Invest. Partnering Russia" is the successful Russian action aimed at activation of business contacts of the companies and investors in the field of "life sciences".
The forum was founded in 2011 and is held with assistance of the Government of St. Petersburg, Committee on industrial policy and innovations of St. Petersburg, the Ministry of Economic Development, the Ministry of Industry and Trade of the Russian Federation, the Ministry of Health of the Russian Federation.
The forum is directed to support of urgent federal initiatives of development of the pharmaceutical market as one of the key spheres providing comfortable life and stability, creating basis for the dynamic economic growth of the country. Unlike the majority of the events held on this subject, the Forum has no pronounced conference focus, concentrating on "live" business communication of participants and on the organizations of discussions on the subjects, most urgent for the industry.
Participants
Already for the ninth time St. Petersburg will meet leading experts in the field of medicine and pharmaceutics at one of the most significant industry events:
IX Annual International Partnering-Forume "Life Sciences Invest. Partnering Russia".
In the center of St. Petersburg, for two days historical halls Talion Imperial of Hotel will turn into discussion platform on discussion of topical issues of the most quickly developing industry in Russia.
Partnering-Forum 2019 will traditionally bring together more than 800 specialists in the field of Life Sciences among which there are representatives of public authorities of the federal and regional level, representatives of research centers and institutes, educational institutions; top managers of the manufacturing companies, developers and suppliers of medicines, products of medical appointment; representatives of the companies developers and distributors of innovative medical products and equipment; representatives of the international and Russian biopharmaceutical and medical companies and many others.
Geography of participants of the Forum 2011 – 2019
Our speakers:

Sergey
Cib
First Deputy Minister of Industry and Trade of the Russian Federation

Elena
Maksimkina
Director of the department of provision of medicines and regulation of the address of medical products of the Ministry of Health of the Russian Federation

Igor
Narkevich
Doctor of pharmaceutical sciences, professor, rector FGBOU VO SPCU of the Russian Ministry of Health

Zakhar
Golant
Vice rector for development FGBOU of VO SPCU of the Russian Ministry of Health, Chairman of the board of the Union "Medico-pharmaceutical projects. 21st century"

Grigory
Potapov
CEO of PJSC Pharmstandard

Dmitry
Chagin
chairman of the board of Association of pharmaceutical producers of the Eurasian Economic Union

Yury
Kalabin
chairman of Committee on industrial policy, innovations and trade of St. Petersburg

Peter
Rodionov
CEO of Geropharm Group

Dmitriy
Kudlay
CEO of JSC Generium

Andrey
Ivashchenko
Chairman of the board of directors of Himrar Group

Vladimir
Khristenko
President of LLC Nanolek

Alexander
Semenov
President and co-owner of CJSC Aktivny Komponent

Denis
Rebrikov
Doctor of Biological Science, the vice rector for scientific work of RNIMU of Pirogov

Vladislav
Shestakov
director of FBU "The State Institute of Medicines and Ought the Practician"

Vladimir
Chekhonin
vice-president of the Russian Academy of Sciences, head of the department of medical nanobiotechnologies of medicobiological faculty FGBOOU WAUGH of "RNIMU of N. I. Pirogov" of the Russian Ministry of Health

Victor
Trukhin
head of the St. Petersburg scientific research institute of vaccines and serums of FMBA of Russia

Anatoly
Shchastny
MD, rector, UO "Vitebsk State Orders of Friendship of the People Medical University"

Aleksandra
Glazkova
deputy CEO for human resource management of JSC BIOCAD

Yury
Zhulev
president of the All-Russian society of hemophilia, cochairman of the All-Russian union of public associations of patients

Elena
Krasilnikova
the analyst, Head of design office "Rare (orphan) diseases" in FGBNU "National research institute of public health of N. A. Semashko

Lyudmila
Sychevskaya
the head of department on the organization of work of pharmaceutical institutions and the enterprises

Dmitry
Madera
head of laboratory of molecular genetics JSC BIOCAD

Kirill
Kai
vice-president of Skolkovo Foundation, executive director of a cluster of biomedical technologies

Elena
Flisyuk
vice rector for scientific work, professor FGBOU of VO SPHFU of the Russian Ministry of Health

Alexey
Smirnov
executive director LLC BALTPHARMA

Heinz
Shmidt
the director of division of LLC Merk in Russia and the CIS

Alexander
Machula
director of science, development and production of LLC BION

Sergey
Klykov
CEO of JSC Sintez

Georgy
Pobelyansky
CEO, JSC VERTEKS

Dmitry
Borisov
commercial director of the company, LLC NTFF Polysan

Vitaly
Kastalsky
lawyer, patent agent of the Russian Federation, Euroasian patent agent, research associate of laboratory of the regulatory relations FGBOU of VO SPHFU of the Russian Ministry of Health

Anna
Guseva
managing partner of the consulting company EY

Alexey
Alyokhin
director of the department of development of the pharmaceutical and medical industry of Minpromtorg of Russia

Pyotr
Kruglyakov
CEO of PJSC Pharmsintez St. Petersburg
Organizers:
With Support
Forum purposes:
- increase in attractiveness of the Russian Life Sciences market for business and investments;
- development of partnership with the leading world clusters and the companies;
- transfer of technologies and creation of infrastructure for innovative development of the sphere of Life Sciences in Russia;
- achievement of the national purposes in the field of protection of public health. Medicinal and food security;
- formation of National medicinal policy in the Russian Federation;
- improvement of system of provision of medicines of the Russian Federation;
- improvement of measures of the state support of the Russian pharmaceutical productions;
- increase in professional level of producers of the medicines and implementation ought the practician (GxP);
- development of organizational and technological infrastructure;
- development pharmaceutical, medical, food, cosmetic and allied industries of the industry;
- practical questions of functionality and increase in quality control of semi-products for the food and cosmetic industry;
- innovations in pharmacy, medicine, pharmacology and toxicology personnel policy, improvement of system of training of specialists